Spyre expands SPY003 license to all therapeutic uses, but faces dosing delays until 2030
Filed June 1, 2026 · Period ending May 29, 2026 · ~1 min read
4 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade SYRE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 1, 2026 8:05 PM